Microvision Delivers World's First Full Color, Daylight Readable, See-Through Display

Spectrum(TM) Prototype Delivered to the Cleveland Clinic Foundation for

Evaluation in Surgical Applications



Apr 10, 2001, 01:00 ET from Microvision, Inc.

    BOTHELL, Wash., April 10 /PRNewswire/ -- Underscoring its market strategy
 as the world's most advanced visualization company, Microvision Inc.
 (Nasdaq:   MVIS) today announced that it has delivered Spectrum -- its prototype
 full-color display system -- to the Cleveland Clinic Foundation. The delivery
 represents the first in a series of full-color, high-resolution,
 daylight-readable, see-through display prototypes that Microvision will
 strategically place with select customers this year.
     As Microvision's first development partner for Spectrum, the Cleveland
 Clinic will focus on developing and evaluating clinical applications in the
 operating room -- a perfect trial to test Spectrum's capabilities, said
 Tom Sanko, Microvision vice president of marketing. Experiencing what
 Microvision calls 'augmented vision' -- electronic images that are
 superimposed over the real world -- surgeons will view full-color images as
 well as patient data and vital signs via Spectrum's head-mounted display.
 Spectrum incorporates Microvision's retinal scanning display (RSD) technology
 -- which 'paints' rows of pixels on the user's eye -- delivering image quality
 far beyond any comparable display technology.
     "The Spectrum color display rivals the quality of high definition
 television; it is absolutely riveting," noted Sanko. "It demonstrates our
 ability to deliver full-color, high-resolution solutions using RSD technology.
 While our monochrome Nomad display will be the cost-effective display solution
 that meets the needs of the vast majority of our users, Spectrum will fill the
 demand for specific full-color applications such as rendering medical images
 in surgical applications."
     Other mission-critical applications that demand a high-end color display
 may include advanced forms of augmented reality such as image-guided surgery
 or flight simulation.
     While Microvision previously produced and delivered a color see-through
 prototype system to Wallace-Kettering Neuroscience Institute in 1999, the
 Spectrum display reflects the innovative advances that Microvision has made in
 full-color RSD technology, said Sanko. The Spectrum display system consists of
 a full-color, high-resolution (SVGA), monocular head-mounted display that is
 tethered to a stationary light source. Spectrum can be configured as a
 biocular (two eyes) or binocular (stereoscopic) display as well. Spectrum also
 features a smaller footprint -- the light sources and electronic components
 comprise a single box one-third the size of its predecessor.
     The Spectrum system prototype availability complements the anticipated
 release of the Nomad(TM) display system, which will be Microvision's first
 commercial product when it is launched this fall. Microvision plans to place
 several additional Spectrum prototypes this year and the company is actively
 seeking potential partners to help develop Spectrum applications.
 
     About Microvision
     Headquartered in Bothell, Wash., Microvision, Inc. is the developer of the
 patented retinal scanning display technology and a world leader in
 micro-miniature optical scanning technology for display and imaging
 applications. The company's technology has application in a broad range of
 military, medical, industrial, professional and consumer information products.
 Additional information can be found at the company's web site at
 http://www.mvis.com
 
     Forward Looking Statement
     The information set forth in this release includes "forward-looking
 statements" within the meaning of Section 21E of the Securities Exchange Act
 of 1934, as amended, and is subject to the safe harbor created by those
 sections. Certain factors that realistically could cause results to differ
 materially from those projected in the company's forward-looking statements
 are set forth in the company's Annual Report on Form 10-K and Quarterly
 Reports on Form 10-Q, as filed with the Securities and Exchange Commission.
 
 

SOURCE Microvision, Inc.
    BOTHELL, Wash., April 10 /PRNewswire/ -- Underscoring its market strategy
 as the world's most advanced visualization company, Microvision Inc.
 (Nasdaq:   MVIS) today announced that it has delivered Spectrum -- its prototype
 full-color display system -- to the Cleveland Clinic Foundation. The delivery
 represents the first in a series of full-color, high-resolution,
 daylight-readable, see-through display prototypes that Microvision will
 strategically place with select customers this year.
     As Microvision's first development partner for Spectrum, the Cleveland
 Clinic will focus on developing and evaluating clinical applications in the
 operating room -- a perfect trial to test Spectrum's capabilities, said
 Tom Sanko, Microvision vice president of marketing. Experiencing what
 Microvision calls 'augmented vision' -- electronic images that are
 superimposed over the real world -- surgeons will view full-color images as
 well as patient data and vital signs via Spectrum's head-mounted display.
 Spectrum incorporates Microvision's retinal scanning display (RSD) technology
 -- which 'paints' rows of pixels on the user's eye -- delivering image quality
 far beyond any comparable display technology.
     "The Spectrum color display rivals the quality of high definition
 television; it is absolutely riveting," noted Sanko. "It demonstrates our
 ability to deliver full-color, high-resolution solutions using RSD technology.
 While our monochrome Nomad display will be the cost-effective display solution
 that meets the needs of the vast majority of our users, Spectrum will fill the
 demand for specific full-color applications such as rendering medical images
 in surgical applications."
     Other mission-critical applications that demand a high-end color display
 may include advanced forms of augmented reality such as image-guided surgery
 or flight simulation.
     While Microvision previously produced and delivered a color see-through
 prototype system to Wallace-Kettering Neuroscience Institute in 1999, the
 Spectrum display reflects the innovative advances that Microvision has made in
 full-color RSD technology, said Sanko. The Spectrum display system consists of
 a full-color, high-resolution (SVGA), monocular head-mounted display that is
 tethered to a stationary light source. Spectrum can be configured as a
 biocular (two eyes) or binocular (stereoscopic) display as well. Spectrum also
 features a smaller footprint -- the light sources and electronic components
 comprise a single box one-third the size of its predecessor.
     The Spectrum system prototype availability complements the anticipated
 release of the Nomad(TM) display system, which will be Microvision's first
 commercial product when it is launched this fall. Microvision plans to place
 several additional Spectrum prototypes this year and the company is actively
 seeking potential partners to help develop Spectrum applications.
 
     About Microvision
     Headquartered in Bothell, Wash., Microvision, Inc. is the developer of the
 patented retinal scanning display technology and a world leader in
 micro-miniature optical scanning technology for display and imaging
 applications. The company's technology has application in a broad range of
 military, medical, industrial, professional and consumer information products.
 Additional information can be found at the company's web site at
 http://www.mvis.com
 
     Forward Looking Statement
     The information set forth in this release includes "forward-looking
 statements" within the meaning of Section 21E of the Securities Exchange Act
 of 1934, as amended, and is subject to the safe harbor created by those
 sections. Certain factors that realistically could cause results to differ
 materially from those projected in the company's forward-looking statements
 are set forth in the company's Annual Report on Form 10-K and Quarterly
 Reports on Form 10-Q, as filed with the Securities and Exchange Commission.
 
 SOURCE  Microvision, Inc.